{
  "id": 2035413,
  "title": "Astera Labs general counsel Philip Mazzara sells $2.31m in stock",
  "url": "https://urgent.news/2026/08/19/astera-labs-general-counsel-philip-mazzara-sells-2-31m-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-19T23:01:01.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/astera-labs-general-counsel-philip-mazzara-sells-231m-in-stock-93CH-4868424"
  },
  "original_language": "en",
  "account": "Astera Labs' General Counsel, Philip Mazzara, sold 7,001 shares of the company's common stock on August 17, 2026, amounting to roughly $2.31 million. The transactions occurred at prices between $333.64 and $352.10 per share. Mazzara's sales were not discretionary; they were to meet tax withholding obligations tied to the vesting of restricted stock units. After these sales, Mazzara now owns 96,542 shares of Astera Labs. Despite the stock's 74% return year-to-date and current price of $289.80, which is lower than the sales price range, InvestingPro suggests the company is overvalued. Astera Labs released strong Q2 2026 financial results, reporting $392.4 million in revenue, up 104% year-over-year, and earnings per share of $0.80, exceeding the analyst forecast of $0.69. These figures have caught the attention of analysts, with Northland upgrading the stock to Outperform and Needham increasing its price target to $425.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}